Invention Grant
- Patent Title: Chikungunya virus antigen constructs
-
Application No.: US16631557Application Date: 2018-07-19
-
Publication No.: US11649467B2Publication Date: 2023-05-16
- Inventor: Benjamin Wizel , Martine Harvey , Lucile Warter , Kate Luisi
- Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
- Current Assignee Address: BE Rixensart
- International Application: PCT/IB2018/055389 2018.07.19
- International Announcement: WO2019/016756A 2019.01.24
- Date entered country: 2020-01-16
- Main IPC: C12N15/86
- IPC: C12N15/86 ; A61K39/12
Abstract:
The invention provides adenoviral vectors comprising transgenes encoding Chikungunya virus antigens. The vectors can be used to produce vaccines for the prophylaxis, amelioration and treatment of diseases caused by Chikungunya virus infections.
Public/Granted literature
- US20200172930A1 CHIKUNGUNYA VIRUS ANTIGEN CONSTRUCTS Public/Granted day:2020-06-04
Information query
IPC分类:
